Orna Reges
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Orna Reges has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Morton Leibowitz
Clalit Research Institute, Clalit Health Services, Tel Aviv, Israel
2 shared publicationsMoshe Hoshen
Clalit Research Institute, Clalit Health Services, Tel Aviv, Israel
2 shared publicationsPhilip Greenland
Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois
2 shared publications- Ran D. Balicer
Clalit Research Institute, Innovation Division, Clalit Health Services, Ramat Gan, Israel
2 shared publications - Chandra Cohen-Stavi
Clalit Research Institute, Chief Physician's Office, Clalit Health Services, 101 Arlozorov Street, Tel Aviv, Israel
1 shared publication Dror Dicker
Internal Medicine Department D and EASO Collaborating Center for Obesity Management at Hasharon Hospital, Rabin Medical Center, Petach Tikva, Israel
1 shared publication
Latest Publications
- Top Cited PapersOpen Access
- 16 January 2018
- Published by American Medical Association (AMA) in JAMA
- Vol. 319 (3) , 279-290
Association of Bariatric Surgery Using Laparoscopic Banding, Roux-en-Y Gastric Bypass, or Laparoscopic Sleeve Gastrectomy vs Usual Care Obesity Management With All-Cause Mortality
Although much is known about short-term outcomes after bariatric surgery,1,2 relatively little is known about the long-term effects of these operations.3 Several reviews have reported long-term results on weight loss and diabetes control,4,5 and a recent study demonstrated beneficial, long-term effects for gastric bypass but was limited by a fairly homogeneous population and operations that were performed by only a few surgeons.2,6 A large (2500 patients) retrospective cohort study from the US Veterans Affairs system7 of patients who underwent bariatric procedures (74% gastric bypass, 10% laparoscopic banding, and 15% laparoscopic sleeve gastrectomy) showed reduced mortality attributable to bariatric surgery. That study’s generalizability was also limited because the patients were mostly men; in the general population, this surgery is performed more often on women.
- 16 January 2018
- Published by American Medical Association (AMA) in JAMA
- Vol. 319 (3) , 279-290
Top Cited PapersOpen AccessAssociation of Bariatric Surgery Using Laparoscopic Banding, Roux-en-Y Gastric Bypass, or Laparoscopic Sleeve Gastrectomy vs Usual Care Obesity Management With All-Cause Mortality
Although much is known about short-term outcomes after bariatric surgery,1,2 relatively little is known about the long-term effects of these operations.3 Several reviews have reported long-term results on weight loss and diabetes control,4,5 and a recent study demonstrated beneficial, long-term effects for gastric bypass but was limited by a fairly homogeneous population and operations that were performed by only a few surgeons.2,6 A large (2500 patients) retrospective cohort study from the US Veterans Affairs system7 of patients who underwent bariatric procedures (74% gastric bypass, 10% laparoscopic banding, and 15% laparoscopic sleeve gastrectomy) showed reduced mortality attributable to bariatric surgery. That study’s generalizability was also limited because the patients were mostly men; in the general population, this surgery is performed more often on women.
- 7 April 2017
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
- Vol. 24 (10) , 1083-1092
Diabetes control: Incidence of acute myocardial infarction and all-cause mortality among patients with 3–6 years’ disease duration
Optimal glycated haemoglobin (HbA1c) concentrations to minimize large vessel complications and prolong life in diabetes patients are not well established. A retrospective cohort study from 2010 to 2012 using data from the Clalit Health Service (Clalit) integrated healthcare system’s electronic data warehouse. Patients included had newly incident diabetes, had at least two HbA1c measurements during the 3 years prior to 1 January 2010 without any disruption(s) in Clalit membership between 2010 and 2014. Time-dependent variables were utilized for HbA1c concentration exposure at three time periods. Diabetes control was evaluated taking average HbA1c measures per time period. Unadjusted and adjusted extended Cox regression analyses assessed the association between time-dependent average HbA1c level and acute myocardial infarction and all-cause mortality. Among our 61,971 participants, 2.0% experienced acute myocardial infarction and 6.9% died. Compared to patients with HbA1c 7.0 to < 7.5%, a higher risk of myocardial infarction was found with 8.5 to < 9.0% (hazard ratio (HR) 1.42, 95% confidence interval (CI) 1.05–1.91) and ≥9.0% (HR 1.87, 95% CI 1.50-2.33) groups; a lower risk was found among <6.0% (HR 0.74, 95% CI 0.59–0.93), 6.0 to < 6.5% (HR 0.77, 95% CI 0.64–0.94) and 6.5 to < 7.0% (HR 0.73, 95% CI 0.60–0.88) groups. The association with all-cause mortality was J-shaped, demonstrating a higher risk in those <6.0% (HR 1.20, 95% CI 1.06–1.34), 7.5 to < 8.0% (HR 1.17, 95% CI 1.02–1.35), 8.0 to < 8.5% (HR 1.38, 95% CI 1.16–1.64), 8.5 to < 9.0% (HR 1.36, 95% CI 1.10–1.67) and ≥9.0% (HR 1.74, 95% CI 1.49–2.04) groups. HbA1c concentration below 6.0% may be associated with an excess risk for all-cause mortality. Clinicians must be aware of this association when treating individual patients.
- 7 April 2017
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
- Vol. 24 (10) , 1083-1092
Diabetes control: Incidence of acute myocardial infarction and all-cause mortality among patients with 3–6 years’ disease duration
Optimal glycated haemoglobin (HbA1c) concentrations to minimize large vessel complications and prolong life in diabetes patients are not well established. A retrospective cohort study from 2010 to 2012 using data from the Clalit Health Service (Clalit) integrated healthcare system’s electronic data warehouse. Patients included had newly incident diabetes, had at least two HbA1c measurements during the 3 years prior to 1 January 2010 without any disruption(s) in Clalit membership between 2010 and 2014. Time-dependent variables were utilized for HbA1c concentration exposure at three time periods. Diabetes control was evaluated taking average HbA1c measures per time period. Unadjusted and adjusted extended Cox regression analyses assessed the association between time-dependent average HbA1c level and acute myocardial infarction and all-cause mortality. Among our 61,971 participants, 2.0% experienced acute myocardial infarction and 6.9% died. Compared to patients with HbA1c 7.0 to < 7.5%, a higher risk of myocardial infarction was found with 8.5 to < 9.0% (hazard ratio (HR) 1.42, 95% confidence interval (CI) 1.05–1.91) and ≥9.0% (HR 1.87, 95% CI 1.50-2.33) groups; a lower risk was found among <6.0% (HR 0.74, 95% CI 0.59–0.93), 6.0 to < 6.5% (HR 0.77, 95% CI 0.64–0.94) and 6.5 to < 7.0% (HR 0.73, 95% CI 0.60–0.88) groups. The association with all-cause mortality was J-shaped, demonstrating a higher risk in those <6.0% (HR 1.20, 95% CI 1.06–1.34), 7.5 to < 8.0% (HR 1.17, 95% CI 1.02–1.35), 8.0 to < 8.5% (HR 1.38, 95% CI 1.16–1.64), 8.5 to < 9.0% (HR 1.36, 95% CI 1.10–1.67) and ≥9.0% (HR 1.74, 95% CI 1.49–2.04) groups. HbA1c concentration below 6.0% may be associated with an excess risk for all-cause mortality. Clinicians must be aware of this association when treating individual patients.
- 1 July 2014
- Published by Elsevier in International Journal of Cardiology
- Vol. 174 (3) , 773-774
Reduction in myocardial infarction incidence: Focus on socioeconomic disparities
- 1 July 2014
- Published by Elsevier in International Journal of Cardiology
- Vol. 174 (3) , 773-774
Reduction in myocardial infarction incidence: Focus on socioeconomic disparities